GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians.

GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training of a new generation of glyco-scientists and entrepreneurs. The network includes over 170 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.

GlycoNet is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.

0
Network Investigators
0
Trained HQP
0
Funded Projects
0
Network Partners

Latest News

Using plants to find new treatments for type 2 diabetes

GlycoNet researchers found more efficient ways to produce montbretin A, a potential anti-diabetes compound.

GlycoNet Investigator receives Canada’s highest honour for science and engineering research

Dr. Molly Shoichet is awarded the Gerhard Herzberg Canada Gold Medal for Science and Engineering from NSERC.

GlycoNet Heart transplant expert exploring connection between glycans in blood group and COVID-19

Pediatric cardiologist Lori West is one of six researchers from the University of Alberta receiving $2.8 million in federal funding for “exceptional opportunities” in fight against the pandemic.

Quick Links

Upcoming Events

There are no upcoming events.

Network Members

© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.

en_USEnglish
Scroll to Top